Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Immunisation”

618 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 618 results

Large-scale testing (Phase 3)Ended earlyNCT05247307
What this trial is testing

Efficacy of the Infusion of Donor Plasma in COVID-19 Infection

Who this might be right for
COVID-19
Hospital Galdakao-Usansolo 93
Not applicableUnknownNCT05186571
What this trial is testing

Myopericarditis After Messenger Ribonucleic Acid (mRNA) COVID-19 Vaccination in Children 5-11 Years Old

Who this might be right for
MyopericarditisMyocarditisVaccination; Complications+2 more
Rigshospitalet, Denmark 350,000
Not applicableUnknownNCT04568044
What this trial is testing

Evaluation of Humoral Immunity Following COVID-19 in Pregnancy

Who this might be right for
COVID-19Pregnancy RelatedInfluenza, Human
Imperial College London 128
Not applicableStudy completedNCT04951336
What this trial is testing

RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination

Who this might be right for
COVID-19 Vaccination
University of California, San Diego 90
Early research (Phase 1)UnknownNCT05007275
What this trial is testing

Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers

Who this might be right for
Covid19SARS-CoV-2 Infection
Imperial College London 28
Post-approval studies (Phase 4)Study completedNCT04852861
What this trial is testing

COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine

Who this might be right for
Covid19
Sciensano 145
Not applicableStudy completedNCT05685901
What this trial is testing

Oropharyngeal Immunoprophylaxis With High Polyphenolic Olive Oil as Clinical Spectrum Mitigating Factor in COVID-19.

Who this might be right for
COVID-19
Hospital General Nuestra Señora del Prado 88
Testing effectiveness (Phase 2)Study completedNCT06695130
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Testing effectiveness (Phase 2)Study completedNCT04761822
What this trial is testing

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Who this might be right for
SARS-CoV InfectionCOVID-19Allergic Reaction+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 746
Not applicableStudy completedNCT05612373
What this trial is testing

Message Offering Free Round Trip Ride-Share Ride to Pharmacy

Who this might be right for
COVID-19
University of Pennsylvania 300,000
Not applicableStudy completedNCT05028881
What this trial is testing

COVID-19 Serology in People Living with HIV in Hong Kong

Who this might be right for
HIV InfectionsSARS-CoV-2 InfectionVaccination; Infection
Chinese University of Hong Kong 488
Early research (Phase 1)UnknownNCT05839236
What this trial is testing

COVID-19 Vaccination Detoxification in LDL-C

Who this might be right for
COVID-19 Stress SyndromeCOVID-19 Vaccine Adverse ReactionCOVID-19-Associated Thromboembolism+3 more
Yang I. Pachankis 1
Post-approval studies (Phase 4)Study completedNCT05343871
What this trial is testing

Immunogenicity and Safety of Fractional Booster Dose of COVID-19 Vaccines Available for Use in Pakistan/Brazil: A Phase 4 Dose-optimizing Trial

Who this might be right for
COVID-19
Albert B. Sabin Vaccine Institute 2,354
Large-scale testing (Phase 3)UnknownNCT05534035
What this trial is testing

Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

Who this might be right for
SARS-CoV-2 Infection
Everest Medicines (Singapore) Pte. Ltd. 450
Post-approval studies (Phase 4)Study completedNCT05030974
What this trial is testing

RECOVAC Repeated Vaccination Study

Who this might be right for
Covid19Kidney DiseasesVaccine Response Impaired+1 more
University Medical Center Groningen 336
Early research (Phase 1)Study completedNCT04591717
What this trial is testing

COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers

Who this might be right for
COVID-19
ImmunityBio, Inc. 34
Large-scale testing (Phase 3)Study completedNCT05077176
What this trial is testing

Phase 3 Booster Vaccination Against COVID-19

Who this might be right for
COVID-19Sars-CoV-2 Infection
Health Institutes of Turkey 4,340
Not applicableStudy completedNCT04352582
What this trial is testing

COVID-19 and Vaccination Attitudes

Who this might be right for
COVID-19
University Hospital, Geneva 1,194
Testing effectiveness (Phase 2)Study completedNCT06695117
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Not applicableStudy completedNCT04841785
What this trial is testing

RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients

Who this might be right for
Covid19SARS-CoV InfectionChronic Kidney Diseases
University Medical Center Groningen 4,868
Next Page